GlaxoSmithKline PLC (GSK) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.141x

Based on the latest financial reports, GlaxoSmithKline PLC (GSK) has a cash flow conversion efficiency ratio of 0.141x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX2.22 Billion ≈ $270.35K USD) by net assets (GBX15.75 Billion ≈ $1.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see GlaxoSmithKline PLC market capitalisation for the company's overall valuation and market capitalisation.

GlaxoSmithKline PLC - Cash Flow Conversion Efficiency Trend (1991–2024)

This chart illustrates how GlaxoSmithKline PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.

GlaxoSmithKline PLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of GlaxoSmithKline PLC ranked by their cash flow conversion efficiency. Explore GSK cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Aebi Schmidt Holding AG - Common Stock NASDAQ:AEBI	0.009x
Guararapes Confecções S.A SA:GUAR3	0.075x
CH. Karnchang PCL BK:CK	0.046x
Shanghai Anoky Group SHE:300067	-0.006x
Dios Fastigheter AB ST:DIOS	0.019x
CeriBell, Inc NASDAQ:CBLL	-0.100x
Cresud SA BA:CRES	-0.021x
Oil-Dri Corporation Of America NYSE:ODC	0.077x

Annual Cash Flow Conversion Efficiency for GlaxoSmithKline PLC (1991–2024)

The table below shows the annual cash flow conversion efficiency of GlaxoSmithKline PLC from 1991 to 2024. View GSK live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	GBX13.09 Billion ≈ $1.59 Million	GBX6.55 Billion ≈ $797.43K	0.501x	-5.32%
2023-12-31	GBX12.79 Billion ≈ $1.56 Million	GBX6.77 Billion ≈ $823.47K	0.529x	-27.86%
2022-12-31	GBX10.10 Billion ≈ $1.23 Million	GBX7.40 Billion ≈ $900.73K	0.733x	+96.80%
2021-12-31	GBX21.34 Billion ≈ $2.60 Million	GBX7.95 Billion ≈ $967.53K	0.373x	-8.15%
2020-12-31	GBX20.81 Billion ≈ $2.53 Million	GBX8.44 Billion ≈ $1.03 Million	0.406x	-7.15%
2019-12-31	GBX18.36 Billion ≈ $2.23 Million	GBX8.02 Billion ≈ $975.80K	0.437x	-80.95%
2018-12-31	GBX3.67 Billion ≈ $446.78K	GBX8.42 Billion ≈ $1.02 Million	2.293x	+15.66%
2017-12-31	GBX3.49 Billion ≈ $424.51K	GBX6.92 Billion ≈ $841.72K	1.983x	+51.46%
2016-12-31	GBX4.96 Billion ≈ $603.85K	GBX6.50 Billion ≈ $790.50K	1.309x	+352.40%
2015-12-31	GBX8.88 Billion ≈ $1.08 Million	GBX2.57 Billion ≈ $312.57K	0.289x	-72.41%
2014-12-31	GBX4.94 Billion ≈ $600.57K	GBX5.18 Billion ≈ $629.77K	1.049x	+13.43%
2013-12-31	GBX7.81 Billion ≈ $950.49K	GBX7.22 Billion ≈ $878.71K	0.924x	+42.57%
2012-12-31	GBX6.75 Billion ≈ $820.91K	GBX4.38 Billion ≈ $532.31K	0.648x	-8.42%
2011-12-31	GBX8.83 Billion ≈ $1.07 Million	GBX6.25 Billion ≈ $760.44K	0.708x	+1.52%
2010-12-31	GBX9.74 Billion ≈ $1.19 Million	GBX6.80 Billion ≈ $827.00K	0.697x	-4.45%
2009-12-31	GBX10.74 Billion ≈ $1.31 Million	GBX7.84 Billion ≈ $954.02K	0.730x	-16.95%
2008-12-31	GBX8.32 Billion ≈ $1.01 Million	GBX7.31 Billion ≈ $889.54K	0.879x	+50.31%
2007-12-31	GBX9.91 Billion ≈ $1.21 Million	GBX5.79 Billion ≈ $705.08K	0.585x	+42.54%
2006-12-31	GBX9.65 Billion ≈ $1.17 Million	GBX3.96 Billion ≈ $481.57K	0.410x	-44.42%
2005-12-31	GBX7.57 Billion ≈ $921.05K	GBX5.59 Billion ≈ $679.78K	0.738x	-8.08%
2004-12-31	GBX5.94 Billion ≈ $722.36K	GBX4.77 Billion ≈ $580.01K	0.803x	-3.95%
2003-12-31	GBX5.80 Billion ≈ $706.18K	GBX4.85 Billion ≈ $590.33K	0.836x	+101.83%
2002-12-31	GBX7.39 Billion ≈ $898.91K	GBX3.06 Billion ≈ $372.31K	0.414x	-24.54%
2001-12-31	GBX8.40 Billion ≈ $1.02 Million	GBX4.61 Billion ≈ $560.79K	0.549x	+165.41%
2000-12-31	GBX8.96 Billion ≈ $1.09 Million	GBX1.85 Billion ≈ $225.33K	0.207x	+29.48%
1999-12-31	GBX3.19 Billion ≈ $388.50K	GBX510.00 Million ≈ $62.05K	0.160x	+7.83%
1998-12-31	GBX2.77 Billion ≈ $336.79K	GBX410.00 Million ≈ $49.89K	0.148x	-54.48%
1997-12-31	GBX1.89 Billion ≈ $229.96K	GBX615.00 Million ≈ $74.83K	0.325x	-51.44%
1996-12-31	GBX1.27 Billion ≈ $154.16K	GBX849.00 Million ≈ $103.30K	0.670x	-88.17%
1995-12-31	GBX221.00 Million ≈ $26.89K	GBX1.25 Billion ≈ $152.33K	5.665x	+32.94%
1995-06-30	GBX574.69 Million ≈ $69.92K	GBX2.45 Billion ≈ $297.98K	4.261x	+1983.79%
1994-06-30	GBX5.15 Billion ≈ $626.48K	GBX1.05 Billion ≈ $128.12K	0.205x	+2.74%
1993-06-30	GBX4.66 Billion ≈ $566.62K	GBX927.00 Million ≈ $112.79K	0.199x	+10.25%
1992-06-30	GBX3.64 Billion ≈ $442.76K	GBX657.00 Million ≈ $79.94K	0.181x	-3.65%
1991-06-30	GBX3.28 Billion ≈ $399.32K	GBX615.00 Million ≈ $74.83K	0.187x	--

About GlaxoSmithKline PLC

LSE:GSK UK Drug Manufacturers - General

Market Cap

$931.50 Million

GBX7.66 Trillion GBX

Market Cap Rank

#9329 Global

#34 in UK

Share Price

GBX1906.00

Change (1 day)

-0.26%

52-Week Range

GBX1470.50 - GBX2268.00

All Time High

GBX2268.00